Literature DB >> 6389228

Glucose counterregulation in patients after pancreatectomy. Comparison with other clinical forms of diabetes.

K S Polonsky, K C Herold, J L Gilden, R M Bergenstal, V S Fang, A R Moossa, J B Jaspan.   

Abstract

Glucose and counterregulatory hormone responses to a high-dose (1.7 mU/kg/min) insulin infusion were studied in 6 patients who had undergone total pancreatectomy, and the results were compared with those of normal controls and patients with other clinical forms of diabetes. The maximum increase in the plasma glucagon concentration during hypoglycemia in the pancreatectomized patients (5 +/- 5.6 pg/ml) was less than in normals (121 +/- 22 pg/ml). Type I diabetic subjects (28 +/- 14 pg/ml), and insulin-treated diabetic subjects of recent onset (36 +/- 12 pg/ml) also had reduced responses, while responses were normal in type II diabetic subjects (102 +/- 26 pg/ml). The epinephrine response to the hypoglycemic stimulus was reduced after pancreatectomy (278 +/- 81 pg/ml) and in type I diabetic subjects (628 +/- 244 pg/ml), but was not different from control (858 +/- 126 pg/ml) in type II and recent-onset diabetic patients. There was considerable overlap in counterregulatory hormone responses in individual patients with and without autonomic neuropathy and with normal or undetectable fasting C-peptide concentrations. While the control subjects all experienced symptoms of hypoglycemia within a narrow range of plasma glucose concentrations (35-46 mg/dl), five of the diabetic subjects experienced symptoms of hypoglycemia at plasma glucose levels of greater than or equal to 55 mg/dl, and five had no subjective awareness of hypoglycemia despite plasma glucose levels less than 30 mg/dl.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6389228     DOI: 10.2337/diab.33.11.1112

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  10 in total

Review 1.  Minireview: Glucagon in stress and energy homeostasis.

Authors:  B J Jones; T Tan; S R Bloom
Journal:  Endocrinology       Date:  2012-01-31       Impact factor: 4.736

Review 2.  Neuroendocrine responses to hypoglycemia.

Authors:  Nolawit Tesfaye; Elizabeth R Seaquist
Journal:  Ann N Y Acad Sci       Date:  2010-10-29       Impact factor: 5.691

3.  Unawareness of hypoglycaemia and inadequate hypoglycaemic counterregulation: no causal relation with diabetic autonomic neuropathy.

Authors:  R E Ryder; D R Owens; T M Hayes; M A Ghatei; S R Bloom
Journal:  BMJ       Date:  1990-10-06

4.  Counterregulation in type 2 (non-insulin-dependent) diabetes mellitus. Normal endocrine and glycaemic responses, up to ten years after diagnosis.

Authors:  S R Heller; I A Macdonald; R B Tattersall
Journal:  Diabetologia       Date:  1987-12       Impact factor: 10.122

5.  Diabetogenic role of insulin's counterregulatory hormones in the isletectomized, diabetic goby.

Authors:  J T Haigwood; R M Flores; R Mazloumi; G Ngan; K M Kelley
Journal:  Endocrine       Date:  2000-12       Impact factor: 3.633

Review 6.  Diabetes after pancreatic surgery: novel issues.

Authors:  Marina Scavini; Erica Dugnani; Valentina Pasquale; Daniela Liberati; Francesca Aleotti; Gaetano Di Terlizzi; Giovanna Petrella; Gianpaolo Balzano; Lorenzo Piemonti
Journal:  Curr Diab Rep       Date:  2015-04       Impact factor: 4.810

Review 7.  Adverse effects of exogenous insulin. Clinical features, management and prevention.

Authors:  A W Patrick; G Williams
Journal:  Drug Saf       Date:  1993-06       Impact factor: 5.606

8.  Metabolic consequences of (regional) total pancreatectomy.

Authors:  C M Dresler; J G Fortner; K McDermott; D R Bajorunas
Journal:  Ann Surg       Date:  1991-08       Impact factor: 12.969

9.  Thermoregulatory responses to hyperinsulinaemic hypoglycaemia and euglycaemia in IDDM.

Authors:  D G Maggs; I A Macdonald; R B Tattersall
Journal:  Diabetologia       Date:  1994-07       Impact factor: 10.122

10.  Insulin deficiency with and without glucagon: A comparative study between total pancreatectomy and type 1 diabetes.

Authors:  Fumimaru Niwano; Yoshihisa Hiromine; Shinsuke Noso; Naru Babaya; Hiroyuki Ito; Sara Yasutake; Ippei Matsumoto; Yoshifumi Takeyama; Yumiko Kawabata; Hiroshi Ikegami
Journal:  J Diabetes Investig       Date:  2018-01-29       Impact factor: 4.232

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.